Latest StemCells Stories
StemCells, a clinical-stage biotechnology company, has reported that its proprietary HuCNS-SC product candidate, when transplanted into a well-established animal model, can protect the retina from progressive degeneration.
StemCells, a clinical-stage biotechnology company, has received a $305,000 grant from the National Institute of Diabetes and Digestive and Kidney Diseases to research and develop a potential cell-based therapeutic for liver disease arising from infection by the hepatitis C virus.
- The horn of a unicorn considered as a medical or pharmacological ingredient.
- A winged horse with a single horn on its head; a winged unicorn.